TipRanks
Go Ultimate55% OFF

Oryzon Genomics SA (ORYN) Income Statement

Oryzon Genomics SA Income Statement

Last quarter (Q1 2026), Oryzon Genomics SA's total revenue was $0.00. In Q1, Oryzon Genomics SA's net income was $-1.22M. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 7.36M$ 14.19M$ 0.00$ 10.62M
$ -133.91K$ 7.06M$ 13.95M$ 15.23M$ 9.87M
$ 6.29M$ 11.48M$ 18.50M$ 20.72M$ 16.88M
Depreciation and Amortization$ 133.91K$ 147.75K$ 152.88K$ 166.66K$ 144.33K
$ -6.29M$ -4.43M$ -4.41M$ -5.33M$ -6.88M
$ -6.42M$ -4.42M$ -4.55M$ -5.49M$ -7.01M
$ 820.43K$ -1.15M$ -1.55M$ -1.07M$ -169.00K
$ -5.60M$ -5.57M$ -6.10M$ -6.56M$ -7.18M
$ -2.61M$ -3.67M$ -3.35M$ -4.23M$ -4.69M
Per Share Metrics
Basic EPS$ -0.04$ -0.06$ -0.06$ -0.08$ -0.09
Diluted EPS$ -0.04$ -0.06$ -0.06$ -0.08$ -0.09
Weighted Average Shares Outstanding74.37M64.37M60.88M56.04M52.76M
Weighted Average Shares Outstanding (Diluted)74.37M64.37M60.88M56.04M52.76M

Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

-8M08M16M-36000 %-24000 %-12000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin